Age specific incidence of antibodies.
(16-3%) and West Nile (17-4%) than between tanapox and Chikungunya (6 8%), and there are similarities between tanapox and West Nile in sex, tribe, and age specific incidence. The nematode parasite Strongyloides stercoralis is familiar as a common parasite of the intestinal tract, especially in tropical and subtropical areas.
It shares with some other intestinal nematodes the ritual of passing through the respiratory tract during its stage of migration after entry into the body, before achieving full maturity in the intestines. It is not generally appreciated, however, that it may settle down in the respiratory tract, mature, and "produce progeny" there (Fiillebom, 1914; Faust, 1935) . The manifestations of respiratory strongyloidiasis need to be more widely known, and the possible consequences of inappropriate treatment when the correct diagnosis is missed deserve emphasis.
We report a case of pulmonary strongyloidiasis presenting Department of Medicine, University of Nigeria, Enugu Campus, Nigeria C. NWOKOLO, F.R.C.P., Professor of Medicine Department of Microbiology, University of Ibadan, Nigeria E. A. E. IMOHIOSEN, Ph.D., Lecturer in Microbiology with wheezing and chronic cough which had been treated as asthma before the condition was recognized.
Case Report A Nigerian girl aged 15 complained of chronic cough and wheezing of relatively sudden onset of six months' duration. She had recently been receiving treatment without improvement for asthma and later for suspected tuberculosis.
There was no family history of asthma or tuberculosis. On examination, she was breathless and wheezed audibly, but otherwise looked well and was apyrexial.
Chest examination showed scattered rales and rhonchi more noticeable on the left side than on the right. No other abnormal signs were noted.
The chest radiograph was normal and the Mantoux tuberculin test was negative.
Microscopical examination of unstained sputum and centrifuged deposits showed large numbers of strongyloides larvae, and ova in various stages of embryonation (see fig. 1 ). All larvae were of the rhabditiform type, measuring 150 by 20 microns and showing the characteristic short narrow buccal cavity and club-shaped oesophagus followed by a bulbous dilation ( fig. 2) . No filariform larvae were seen.
The stool showed some ova of hookworms, but no strongyloides larvae or ova. The urine was normal. Haemoglobin was 12-5 g/100 ml, W.B.C. 10,300/mm3. The exaiination on the thirteenth day showed only 0-2 larvae and no eggs per low power field. She was then discharged, but treatment with diethylcarbamazine was continued for seven days more.
When seen eight weeks later, she looked well, but had a slight cough without wheezing. Strongyloides eggs were again present in the sputum and there were 1-3 larvae per low power field. She was then given further thiabendazole treatment (25 mg/kg daily) for two weeks in an attempt to eradicate the parasite completely.
At the time of writing she had not reported for a follow-up amination, and efforts to trace her have been initiated.
Comment
Strongyloides larvae may rarely appear in the sputum under the following three conditions:
(1) Filariform larvae (second stage migratory larvae) may appear during the course of the initial migration from the skin or buccal mucosa through the lungs to the intestines (Faust et al., 1970) .
(2) In autoinfection (Fulleborn, 1914 , De Paola, 1961 (x 3,180.) for example, in severe debilitating diseases or malnutrition or during corticosteroid or other immunosuppressive therapy in a patient already suffering from intestinal strongyloidiasis.
(3) Rhabditiform larvae (first stage non-migratory larvae) together with strongyloides eggs may be coughed up in the sputum persistently in the situation in which for some inexplicable reason filariform larvae mature, and multiply in the lungs instead of proceeding to the intestines (Faust, 1935) . The present patient belonged to this group. Treatment in this case with standard doses of thiabendazole was unsuccessful and diethylcarbamazine had to be substituted with some apparent benefit. Seabury and Savoy (1971) had a similar unfavourable experience with thiabendazole given for three weeks in a fatal case of pulmonary strongyloidiasis in a 70-year-old man.
Fortunately, our patient did not appear to have received corticosteroids at any time for her presumed asthma. This might have aggravated her condition. This is because there is evidence that a relatively harmless strongyloides parasite can be converted into a dangerous pathogen with pronounced invasive tendencies by the administration of steroids or other immunosuppressive drugs to the host (Willis and Nwokolo, 1966; Rivera et al., 1970; Fagundes et al., 1971) .
Physicians who treat asthma often add corticosteroids to their antiasthmatic regimens whenever standard therapy is unsuccessful. This practice could be dangerous if the "asthma" is associated with pulmonary strongyloidiasis and steroid therapy is prolonged. Because of this, it is suggested that asthmatic patients from areas where strongyloidiasis is endemic should have sputum examinations for strongyloides before they are subjected to a course of steroids, most especially where an eosinophilia is found in the blood.
